Accendra Health Inc (ACH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | 22,389 | N/A | N/A |
| Depreciation Amortization | N/A | N/A | 228,667 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | -26,361 | N/A | N/A |
| Accounts receivable | N/A | N/A | 4,416 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 13,652 | N/A | N/A |
| Other Working Capital | N/A | N/A | 93,436 | N/A | N/A |
| Other Operating Activity | 1,460,537 | 577,746 | -11,193 | 2,927,284 | 2,265,364 |
| Operating Cash Flow | $1,460,537 | $577,746 | $325,006 | $2,927,284 | $2,265,364 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -259,341 | -134,872 | -109,707 | -374,427 | -208,283 |
| Net Acquisitions | N/A | 1 | -1,684,607 | 16,677 | 16,580 |
| Purchase Of Investment | -573,030 | -11,974 | N/A | -2,268,000 | -1,512,000 |
| Sale Of Investment | 25,832 | 3,745 | N/A | 1,512,004 | 756,000 |
| Purchase Sale Intangibles | -1,692 | N/A | -8,492 | N/A | -51 |
| Other Investing Activity | 5,514 | 33,525 | -10,162 | 54,292 | 51,306 |
| Investing Cash Flow | $-801,025 | $-109,574 | $-1,804,476 | $-1,059,454 | $-896,396 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,485,226 | N/A | N/A | N/A | 2,462,946 |
| Debt Issued | N/A | 1,174,026 | 2,743,300 | 2,697,352 | N/A |
| Debt Repayment | N/A | -1,679,686 | -1,160,800 | -3,557,560 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 52,284 |
| Dividend Paid | -65,446 | -82,300 | N/A | -412,457 | N/A |
| Other Financing Activity | -2,938,804 | -53,394 | -85,395 | -119,403 | -3,736,844 |
| Financing Cash Flow | $-1,519,024 | $-641,353 | $1,497,105 | $-1,392,068 | $-1,221,614 |
| Exchange Rate Effect | 6,773 | -9,649 | -3,485 | -9,812 | 6,760 |
| Beginning Cash Position | 2,398,059 | 2,458,599 | 72,035 | 2,699,410 | 2,699,410 |
| End Cash Position | 1,545,320 | 2,275,768 | 86,185 | 3,165,361 | 2,853,525 |
| Net Cash Flow | $-852,739 | $-182,831 | $14,150 | $465,950 | $154,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,460,537 | 577,746 | 325,006 | 2,927,284 | 2,265,364 |
| Capital Expenditure | -259,451 | -135,193 | -158,090 | -376,629 | -223,531 |
| Free Cash Flow | 1,201,086 | 442,553 | 166,916 | 2,550,655 | 2,041,833 |